Servier

This study tests an oral drug called ivosidenib in 12 Japanese patients with advanced bile duct cancer that has a specific IDH1 gene mutation. Participants take the pill daily in 28-day cycles until the cancer worsens or side effects become too severe. The goal is to see if the d…

This study tests an experimental drug called vorasidenib in about 57 Asian patients with a slow-growing brain tumor (grade 2 glioma) that has a specific genetic mutation (IDH1 or IDH2). Half the participants get the drug, half get a placebo, and researchers track how long it take…